✦ LIBER ✦

First trimester Down syndrome screening markers in triploidy: a case report

✍ Scribed by Jamie Campbell; Howard Cuckle; Indera Sehmi; Richard Jones

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 88 KB
Volume: 19
Category: Article
ISSN: 0197-3851
DOI: 10.1002/(sici)1097-0223(199911)19:11<1086::aid-pd705>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Appropriate biochemical parameters in fi

Appropriate biochemical parameters in first-trimester screening for Down syndrome

✍ Howard S. Cuckle; Jan M. M. van Lith 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 3 views

Meta-analysis was used to calculate maternal serum marker distribution parameters for Down syndrome risk estimation in the first trimester. Data from 44 series were combined: relating to pregnancy associated plasma protein (PAPP)-A in 18, free human chorionic gonadotrophin (hCG) in 17, -fetoprotein

Combining Ultrasound and Biochemistry in

Combining Ultrasound and Biochemistry in First-Trimester Screening for Down's syndrome

✍ N. J. Wald; A. K. Hackshaw 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 2 views

Data on pregnancies with and without Down's syndrome between 10 and 14 weeks of pregnancy were used to determine the performance of combined ultrasound and biochemical markers in prenatal screening for Down's syndrome. We used three datasets: one published by on nuchal translucency measurement in 8

Maternal serum screening for Down syndro

Maternal serum screening for Down syndrome in the first trimester: experience from Belarus

✍ G. L. Tsukerman; N. B. Gusina; H. S. Cuckle 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 2 views

We have carried out a large retrospective study of -fetoprotein (AFP), free-human chorionic gonadotrophin (hCG) and pregnancy-associated plasma protein (PAPP-A) in the first trimester of pregnancy. Unlike other studies all women had routine ultrasound dating, carried out during a nuchal translucency

COMBINING INHIBIN A WITH EXISTING SECOND

COMBINING INHIBIN A WITH EXISTING SECOND-TRIMESTER MARKERS IN MATERNAL SERUM SCREENING FOR DOWN'S SYNDROME

✍ H. S. CUCKLE; S. HOLDING; R. JONES; N. P. GROOME; E. M. WALLACE 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 2 views

To assess the value of inhibin A as an additional second-trimester maternal serum marker of Down's syndrome we studied 56 affected and 280 unaffected pregnancies matched for gestational age. The median level in the cases was 1.62 multiples of the gestation-specific median (MOM) in the controls, with

LETTER TO THE EDITOR. ULTRASOUND DATING

LETTER TO THE EDITOR. ULTRASOUND DATING IN FIRST-TRIMESTER BIOCHEMICAL SCREENING FOR DOWN SYNDROME

✍ A. BORRELL; M. T. FARRÉ; D. COSTA; A. FORTUNY 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views

Ultrasound dating in first-trimester biochemical screening for Down syndrome We have read with interest the article by Macintosh ef al. (1995) which describes the effects of ultrasound estimation of gestational age on the performance of first-trimester biochemical screening for fetal aneuploidy. I

Agreement between predicted risk and pre

Agreement between predicted risk and prevalence of Down syndrome in second-trimester triple-marker screening in Japan

✍ Takekazu Onda; Tadao Tanaka; Osamu Takeda; Michihiro Kitagawa; Yoshinori Kuwabar 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

Based on 9350 pregnant Japanese women who were screened by serum triple-marker determination, accuracy of predicted risk for Down syndrome was examined using 24 Down syndrome cases detected either prenatally or postnatally. The correlation is statistically very high (r=0•98) between the predicted ri